- Home
- LDI vs TSHA Comparison
LDI vs TSHA Comparison
Compare LDI & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDI
- TSHA
- Stock Information
- Founded
- LDI 2010
- TSHA 2019
- Country
- LDI United States
- TSHA United States
- Employees
- LDI N/A
- TSHA N/A
- Industry
- LDI Finance: Consumer Services
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- LDI Finance
- TSHA Health Care
- Exchange
- LDI Nasdaq
- TSHA Nasdaq
- Market Cap
- LDI 314.1M
- TSHA 334.1M
- IPO Year
- LDI 2021
- TSHA 2020
- Fundamental
- Price
- LDI $1.37
- TSHA $1.72
- Analyst Decision
- LDI Sell
- TSHA Strong Buy
- Analyst Count
- LDI 3
- TSHA 8
- Target Price
- LDI $2.03
- TSHA $6.63
- AVG Volume (30 Days)
- LDI 1.2M
- TSHA 1.6M
- Earning Date
- LDI 03-11-2025
- TSHA 02-26-2025
- Dividend Yield
- LDI N/A
- TSHA N/A
- EPS Growth
- LDI N/A
- TSHA N/A
- EPS
- LDI N/A
- TSHA N/A
- Revenue
- LDI $985,646,000.00
- TSHA $8,333,000.00
- Revenue This Year
- LDI N/A
- TSHA N/A
- Revenue Next Year
- LDI $12.46
- TSHA N/A
- P/E Ratio
- LDI N/A
- TSHA N/A
- Revenue Growth
- LDI 5.26
- TSHA N/A
- 52 Week Low
- LDI $1.27
- TSHA $1.19
- 52 Week High
- LDI $3.23
- TSHA $4.32
- Technical
- Relative Strength Index (RSI)
- LDI 30.93
- TSHA 54.32
- Support Level
- LDI $1.27
- TSHA $1.66
- Resistance Level
- LDI $1.91
- TSHA $1.79
- Average True Range (ATR)
- LDI 0.12
- TSHA 0.11
- MACD
- LDI -0.03
- TSHA 0.01
- Stochastic Oscillator
- LDI 15.63
- TSHA 47.62
About LDI loanDepot Inc.
loanDepot Inc provides nonbank consumer lending solutions for individuals in the United States. It offers personal, residential home, home refinancing, mortgage and home equity loans. It also provides online mortgage loans for refinancing and home purchases. It serves customers through distribution channels, including consumer direct centres, retail branches, wholesale centres, and consumer finance and servicing centres in the United States. It competes with commercial banks and financial institutions.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.